TRAW
Traws PharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TRAW Profile
Traws Pharma, Inc.
A clinical-stage biopharmaceutical company that developing novel drugs for cancer
12 Penns Trail, Newtown, PA 18940
--
Traws Pharma, Inc., incorporated in Delaware on December 22, 1998 and commenced operations on January 1, 1999, is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule drug candidates for the treatment of cancer. Traws is developing next-generation, best-in-class antiviral drugs for influenza, COVID and other respiratory infections, as well as narazaciclib for oncology.
